arrow_back Trending Legislation
Share share

Easier Access to Pancreatic Islet Transplants by Classifying Them as Organs.

This law changes how pancreatic islet cells used in transplants are regulated, classifying them as organs rather than drugs or biological products. This aims to simplify and speed up access to life-saving transplants for patients, especially those with severe Type 1 diabetes. The new regulatory framework could increase the availability of these procedures.
Key points
Pancreatic islet cells for transplantation will be legally treated as organs, not as drugs or biological products.
This change aims to simplify regulatory processes and potentially increase the availability of transplants for patients.
The Secretary of Health and Human Services must update transplantation regulations within one year.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
ISLET Act
Print number: HR 4304
Sponsor: Rep. Rosendale Sr., Matthew M. [R-MT-2]
Process start date: 2023-06-22
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Easier Access to Pancreatic Islet Transplants by Classifying Them as Organs.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 4304.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-06-22.

What are the main provisions?

Key points include:

  • Pancreatic islet cells for transplantation will be legally treated as organs, not as drugs or biological products.
  • This change aims to simplify regulatory processes and potentially increase the availability of transplants for patients.
  • The Secretary of Health and Human Services must update transplantation regulations within one year.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Rosendale Sr., Matthew M. [R-MT-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

Analysis and Potential Impact of HR 4304

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health